Scientific Advisory Board

The charity has a Scientific Advisory Board with a strong international membership to ensure that funds raised will be spent as effectively as possible.

Role of the Scientific Advisory Board (SAB)

As part of the scientific review process, the Board provides expert advice to the CEO and Trustees on:

  • Development of the charity’s research strategy and grant giving programme
  • External referees for applications (‘peer reviewers’)
  • Assessment of and final recommendations on applications

The SAB also provides advice and support for the charity on reporting and dissemination of research results.

Download the SAB Terms of Reference

Chair of the SAB


Professor Stephen Smith, International Academic and Health Consultancy (previously Dean of the Faculty of Medicine Dentistry and Health Sciences at the University of Melbourne and Chair Melbourne Health Academic Centre)

Lay membership


  • Roy Bowdery, UK, 2018-present
  • Michael Stead, UK, 2018-present
  • Katerina Georgiadis, UK, 2018-present
  • Zoë Buckley, UK, 2018-present
  • Stuart McWilliam, UK, Guest member for 2019-20

Technical membership


  • Professor Carl Borrebaeck, Professor at Department of Immunotechnology, Lund University, Sweden, 2017-present
  • Professor Rajesh Chopra, Head of the Division of Cancer Therapeutics and Director of the Cancer Research UK Cancer Therapeutics Unit, Institute of Cancer Research, London, 2017-present
  • Professor Douglas Fearon, Professor, Cold Spring Harbor Laboratory, USA and University of Cambridge, UK, 2016-present
  • Dr Julie Guillermet-Guibert, INSERM, Toulouse, France, 2017-present
  • Professor Tony Hollingsworth, Associate Director for Basic Research, University of Nebraska, USA, 2017-present
  • Dr Raghu Kalluri, Professor and Chair, MD Anderson Cancer Centre, Texas USA, 2017-present
  • Professor Gillies McKenna, Head of the Department of Oncology, University of Oxford, UK, 2016-present
  • Dr Ilse Rooman, Vrije Universiteit, Belguim, 2017-present
  • Professor Margaret Tempero, Professor of Medicine, Division of Hematology and Oncology, University of California, San Francisco, USA, 2016-present
  • Professor Juan Valle, Professor in Medical Oncology, University of Manchester, UK, 2016-present
  • Professor Daniel Palmer-North West Cancer Research Fund Professor and Honorary Consultant in Medical Oncology, University of Liverpool, UK, Guest member for 2019-20

Previous members of the SAB


  • Professor David Tuveson, Director of the Cold Spring Harbor Laboratory, New York, USA, 2010-2016
  • Professor Aldo Scarpa, Università di Verona, Italy, 2010-2017
  • Dr Kyoichi Takaori, Kyoto University, Graduate School of Medicine, Kyoto, Japan, 2013-2017
  • Professor Jim Abbruzzese, Chief of the Division of Medical Oncology and Associate Director for Clinical Research, Duke University, North Carolina, USA, 2010-2019
  • Professor Andrew Biankin, Regius Chair of Surgery/Director of Translational Research Centre, Wolfson Wohl Cancer Research Centre, University of Glasgow, UK, 2010-2019
  • Professor Helmut Friess, Department of Surgery, Technische Universität München, Germany, 2010-2019
  • Professor Francisco Real, Programa de Patología Molecular, Centro Nacional de Investigaciones Oncológicas, Madrid, Spain, 2010-2019
  • Professor Eithne Costello, Pancreas Research Group, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, UK, 2013-2019
  • Professor Nick Lemoine, Director of the Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, University of London, UK, 2013-2019
  • Professor Kenneth Hess, Professor of Biostatistics, MD Andersor Cancer Centre, Texas USA, 2017-2019
  • John Nathan, Lay Member, UK, 2014-2017
  • Catherine McGrath, Lay Member, UK, 2014-2017
  • Dr Anna Gerring, Lay Member, UK, 2018-2019

Clinical Pioneer Awards Review Panel 2019-20

This review panel was put together to make recommendations of funding to the Board of Trustees for the Clinical Pioneer Award Scheme. The Clinical Pioneer Awards focus on improving care for people with pancreatic cancer and therefore this bespoke panel is Chaired by the Chair of our SAB and is made up of clinical and lay experts from around the UK.

Clinical Pioneer Award Review Panel membership


Chair:

  • Professor Stephen Smith, Chair of the Scientific Advisory Board, International Academic and Health Consultancy (previously Dean of the Faculty of Medicine Dentistry and Health Sciences at the University of Melbourne and Chair Melbourne Health Academic Centre)

Panel members:

  • Vicki Stevenson-Hornby, Macmillan HPB Specialist Nurse, Wigan and Leigh Foundation Trust, UK
  • Professor Giuseppe Kito Fusai, Consultant General HPB Surgeon, Royal Free Hospital, UK
  • Dr Naureen Starling, Consultant Medical Oncologist, The Royal Marsden, UK
  • Oonagh Griffin, Senior Pancreatic Dietician, Trinity College Dublin
  • Ilaria Mirabile, Tranformation Lead (Innovation, Treatment and Care), NHS Cancer Programme, NHS England and NHS Improvement, UK
  • Cath Miller, Project Nurse, Leeds Teaching Hospitals NHS Trust, UK
  • Lesley Goodburn, Lay Member, UK
  • Claire Hopkins, Lay Member, UK

Conflicts of Interest Policy

Pancreatic Cancer UK has a rigorous policy on conflicts of interest in relation to both external peer reviewers and members of the SAB. Note that an important part of this policy is that the Chair or Vice Chair will withdraw from the entire research grants round if it includes any applications from members of his own research team.

Download the policy here